Pattipati Meghana, Gudavalli Goutham, Dhulipalla Lohitha
Internal Medicine, The Brooklyn Hospital Center, Brooklyn, USA.
Critical Care Medicine, Rapides Regional Medical Center, Alexandria, USA.
Cureus. 2022 May 20;14(5):e25157. doi: 10.7759/cureus.25157. eCollection 2022 May.
The effect of comorbid obesity hypoventilation syndrome (OHS) on hospitalized patients with diabetic ketoacidosis (DKA) has not been studied so far. This study elucidates the outcomes of DKA patients with OHS compared to those without OHS.
Patients above 18 years of age were included in the study. The National Inpatient Sample (NIS) database of 2017 and 2018 was used and data were extracted using the International Classification of Diseases, Tenth Revision (ICD-10) codes; OHS ICD-10 code being "E66.2" and DKA ICD-10 codes being "E08.1, E09.1, E10.1, E11.1, and E13.1." The comorbid medical conditions were also identified using the ICD-10 codes. Logistic regression analysis was performed to examine the impact of OHS on in-hospital outcomes of DKA patients.
OHS was prevalent in 0.61% of the general population, as per the NIS database in the years 2017 and 2018. Primary outcomes of the study were in-hospital mortality, whereas secondary outcomes included acute kidney failure, the requirement for invasive mechanical ventilation, length of stay, and cost of hospitalization. OHS in DKA patients was associated with increased mortality (odds ratio (OR): 4.35 (2.63-7.20), p < 0.00001; adjusted OR (aOR): 1.79 (1.01-3.15), p < 0.044), acute kidney failure (OR: 2.44 (1.79-3.33), p < 0.00001; aOR: 1.43 (1.03-2.00), p < 0.031), invasive mechanical ventilation (OR: 4.17 (2.90-5.98), p < 0.00001; aOR: 1.62 (1.08-2.41), p < 0.017), increased length of stay (10.02 ± 12.42 vs. 4.70 ± 6.31, p < 0.00001), and cost of care (132314 ± 197111.8 vs. 54245.06 ± 98079.89, p < 0.00001). All-cause mortality of patients with DKA and OHS using the Cox proportional hazards ratio was 1.70 (1.02-2.84, p < 0.024) after adjusting for age, race, sex, smoking, obesity, and comorbidities such as heart failure, hypertension, chronic obstructive pulmonary disease, chronic ischemic heart disease, chronic kidney disease, liver disease, and cerebral infarction.
OHS is an independent risk factor for mortality in DKA, irrespective of the degree of obesity. Further prospective studies are recommended to study the effects of different treatment modalities of OHS such as identification of the need for early non-invasive ventilation or for early invasive mechanical ventilation to improve outcomes in DKA patients.
迄今为止,合并肥胖低通气综合征(OHS)对糖尿病酮症酸中毒(DKA)住院患者的影响尚未得到研究。本研究阐明了合并OHS的DKA患者与未合并OHS的患者的治疗结果。
本研究纳入了18岁以上的患者。使用了2017年和2018年的全国住院患者样本(NIS)数据库,并使用国际疾病分类第十版(ICD-10)编码提取数据;OHS的ICD-10编码为“E66.2”,DKA的ICD-10编码为“E08.1、E09.1、E10.1、E11.1和E13.1”。还使用ICD-10编码确定了合并的内科疾病。进行逻辑回归分析以检验OHS对DKA患者住院结局的影响。
根据2017年和2018年的NIS数据库,OHS在普通人群中的患病率为0.61%。该研究的主要结局是住院死亡率,次要结局包括急性肾衰竭、有创机械通气需求、住院时间和住院费用。DKA患者中的OHS与死亡率增加相关(比值比(OR):4.35(2.63 - 7.20),p < 0.00001;调整后的OR(aOR):1.79(1.01 - 3.15),p < 0.044)、急性肾衰竭(OR:2.44(1.79 - 3.33),p < 0.00001;aOR:1.43(1.03 - 2.00),p < 0.031)、有创机械通气(OR:4.17(2.90 - 5.98),p < 0.00001;aOR:1.62(1.08 - 2.41),p < 0.017)、住院时间延长(10.02 ± 12.42对4.70 ± 6.31,p < 0.00001)和护理费用增加(132314 ± 197111.8对54245.06 ± 98079.89,p < 0.00001)。在对年龄、种族、性别、吸烟、肥胖以及心力衰竭、高血压、慢性阻塞性肺疾病、慢性缺血性心脏病、慢性肾病、肝病和脑梗死等合并症进行调整后,使用Cox比例风险比得出的DKA和OHS患者的全因死亡率为1.70(1.02 - 2.84,p < 0.024)。
OHS是DKA患者死亡的独立危险因素,与肥胖程度无关。建议进一步开展前瞻性研究,以研究OHS不同治疗方式的效果,如确定早期无创通气或早期有创机械通气的需求,以改善DKA患者的结局。